Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: Global distribution of the H30-Rx sublineage

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 3762-3767

  Peirano, Gisele ^a,b   Van Der Bij, Akke K ^c,d   Freeman, Joshua L ^e,f   Poirel, Laurent ^g   Nordmann, Patrice ^g   Costello, Michael ^h   Tchesnokova, Veronika L ⁱ   Pitout, Johann D D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

^e AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g University of Fribourg   (Switzerland)

^h ACL Laboratories   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PARC; QUINOLONE; ADHESIN; BETA LACTAMASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; FIMBRIA PROTEIN; FIMH PROTEIN, E COLI;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CANADA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FRANCE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; INDIA; NETHERLANDS; NEW ZEALAND; NONHUMAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTH AFRICA; UNITED ARAB EMIRATES; UNITED STATES; ANTIBIOTIC RESISTANCE; BACTERIOPHAGE TYPING; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID;

ADHESINS, ESCHERICHIA COLI; BACTERIOPHAGE TYPING; BETA-LACTAMASES; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIMBRIAE PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 84903129800     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02428-14     Document Type: Article

References (34)

1. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686. http://dx.doi.org/10.1128/ CMR.18.4.657-686.2005.
2. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. http://dx.doi.org/10.1016/S1473-3099(08)70041-0. (Pubitemid 351249250)
3. Cantón R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475. http://dx.doi.org/10.1016/j.mib.2006.08.011.
4. Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321. http://dx.doi.org/10.1016/j.ijantimicag. 2009.11.003.
5. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Cantón R, Nordmann P. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. http://dx.doi.org/10.3201/eid1402.070350. (Pubitemid 351213667)
6. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281. http://dx.doi.org/10.1093/jac/ dkm464.
7. Pitout JD, Gregson DB, Campbell L, Laupland KB. 2009. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 53:2846-2851. http://dx.doi.org/10.1128/AAC.00247- 09.
8. Van der Bij AK, Peirano G, Pitondo-Silva A, Pitout JD. 2012. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn. Microbiol. Infect. Dis. 72:297-302. http://dx.doi.org/10.1016/j.diagmicrobio.2011.12.011.
9. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739. http://dx.doi.org/10.1128/AAC.00297- 09.
10. Novais A, Pires J, Ferreira H, Costa L, Montenegro C, Vuotto C, Donelli G, Coque TM, Peixe L. 2012. Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob. Agents Chemother. 56:3973-3976. http://dx.doi.org/10.1128/AAC.00475-12.
11. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-928. http://dx.doi.org/10. 1093/infdis/jis933.
12. Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J, Spanish Group for Nosocomial Infections (GEIH). 2013. Four main virotypes among extended-spectrum-β- lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J. Clin. Microbiol. 51: 3358-3367. http://dx.doi.org/10.1128/JCM.01555-13.
13. Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, Alfa M, Pienaar C, Kibsey P, Pitout JDD. 2010. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-β-lactamase- producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 54:1327-1330. http://dx.doi.org/10.1128/AAC.01338-09.
14. Peirano G, van der Bij AK, Gregson DB, Pitout JD. 2012. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J. Clin. Microbiol. 50:294-299. http://dx.doi.org/10.1128/JCM. 06025-11.
15. Peirano G, Costello M, Pitout JD. 2010. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 36:19-23. http://dx.doi.org/10.1016/j.ijantimicag.2010.02. 016.
16. Peirano G, Asensi MD, Pitondo-Silva A, Pitout JD. 2011. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. Clin. Microbiol. Infect. 17:1039-1043. http://dx.doi.org/10.1111/j.1469-0691.2010.03440.x.
17. van der Bij AK, Peirano G, Goessens WHF, van der Vorm ER, van Westreenen M, Pitout JDD. 2011. Clinical and molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands. Antimicrob. Agents Chemother. 55:3576-3578. http://dx.doi.org/10.1128/AAC.00074-11.
18. Peirano G, van Greune CH, Pitout JD. 2011. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn. Microbiol. Infect. Dis. 69:449-453. http://dx.doi.org/10.1016/j.diagmicrobio.2010.11.011.
19. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Pitout JDD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, Laupland KB. 2007. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob. Agents Chemother. 51:1281-1286. http://dx.doi.org/10.1128/AAC.01377- 06. (Pubitemid 46586806)
21. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874. http://dx.doi.org/10.1128/ AAC.01647-05. (Pubitemid 44198719)
22. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. 2006. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955. http: //dx.doi.org/10.1128/ AAC.00915-06. (Pubitemid 44684926)
23. Yamane K, Wachino J, Suzuki S, Arakawa Y. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52:1564-1566. http://dx.doi.org/10.1128/AAC.01137-07. (Pubitemid 351522037)
24. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
25. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, Wrigley D, Barrett T, Ribot E. 2005. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol. 43:1045-1050. http://dx.doi.org/10.1128/JCM.43.3.1045-1050.2005. (Pubitemid 40364915)
26. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
27. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR. 2013. Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago region (2007-2010). Antimicrob. Agents Chemother. 57:6385-6388. http://dx.doi.org/10.1128/AAC.01604-13.
28. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277. http://dx.doi.org/10.1093/jac/dkp194.
29. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR, VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators. 2013. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin. Infect. Dis. 57:1256-1265. http://dx.doi.org/10.1093/cid/ cit503.
30. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. 2012. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from northwest England. J. Antimicrob. Chemother. 67:346-356. http://dx.doi.org/10.1093/jac/dkr451.
31. Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA, MASTER Investigators. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg. Infect. Dis. 18:598-607. http://dx.doi.org/10.3201/eid1804.111627.
32. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Anderson PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko E. 2013. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4(6):e00377-13. http://dx.doi.org/10.1128/mBio.00377-13.
33. Mora A, Dahbi G, López C, Mamani R, Marzoa J, Dion S, Picard B, Blanco M, Alonso MP, Denamur E, Blanco J. 2014. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS One 9:e87025. http://dx.doi.org/10.1371/journal.pone.0087025.
34. Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E. 5 February 2014. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J. Clin. Microbiol. http://dx.doi.org/10.1128/JCM.03502-13.